Variant report

Variant	rs28697571
Chromosome Location	chr15:31316965-31316966
allele	G/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	YY1	chr15:31316418-31317017	SK-N-SH	brain:	n/a	n/a
2	MAX	chr15:31316414-31317087	A549	lung:	n/a	n/a
3	POLR2A	chr15:31316342-31317122	HUVEC	blood vessel:	n/a	n/a
4	SP1	chr15:31316520-31317075	H1-hESC	embryonic stem cell:	n/a	chr15:31316863-31316877
5	CEBPB	chr15:31316570-31317002	Hela-S3	cervix:	n/a	n/a
6	MAX	chr15:31316407-31316978	SK-N-SH	brain:	n/a	n/a
7	GATA3	chr15:31316340-31317869	SK-N-SH	brain:	n/a	chr15:31317461-31317470 chr15:31316560-31316568 chr15:31316630-31316639
8	MAX	chr15:31316397-31317028	SK-N-SH	brain:	n/a	n/a
9	NFIC	chr15:31316400-31317178	SK-N-SH	brain:	n/a	n/a
10	MAX	chr15:31316324-31317435	A549	lung:	n/a	n/a
11	MAZ	chr15:31316336-31317662	IMR90	lung:	n/a	n/a
12	TEAD4	chr15:31316448-31317128	HepG2	liver:	n/a	n/a
13	SP1	chr15:31316433-31317132	A549	lung:	n/a	chr15:31316863-31316877
14	GABPA	chr15:31316483-31316977	A549	lung:	n/a	n/a
15	TCF7L2	chr15:31316571-31317225	Hela-S3	cervix:	n/a	chr15:31316632-31316641 chr15:31317038-31317054 chr15:31317038-31317054 chr15:31317039-31317053
16	GATA3	chr15:31316290-31317779	SK-N-SH	brain:	n/a	chr15:31317461-31317470 chr15:31316560-31316568 chr15:31316630-31316639
17	TEAD4	chr15:31316564-31317077	A549	lung:	n/a	n/a
18	RAD21	chr15:31316471-31316995	IMR90	lung:	n/a	n/a
19	POLR2A	chr15:31316378-31317123	HUVEC	blood vessel:	n/a	n/a
20	TEAD4	chr15:31316328-31317182	SK-N-SH	brain:	n/a	n/a
21	PBX3	chr15:31316409-31317098	SK-N-SH	brain:	n/a	n/a
22	TEAD4	chr15:31316485-31317174	A549	lung:	n/a	n/a
23	RXRA	chr15:31316338-31316986	SK-N-SH	brain:	n/a	n/a
24	TCF7L2	chr15:31316608-31316972	PANC-1	pancreas:	n/a	chr15:31316632-31316641
25	TEAD4	chr15:31316499-31317128	H1-hESC	embryonic stem cell:	n/a	n/a
26	SP1	chr15:31316598-31316986	H1-hESC	embryonic stem cell:	n/a	chr15:31316863-31316877
27	CEBPB	chr15:31316515-31317481	IMR90	lung:	n/a	n/a
28	TEAD4	chr15:31316512-31316996	ECC-1	luminal epithelium:	n/a	n/a
29	JUN	chr15:31316074-31317022	HUVEC	blood vessel:	n/a	chr15:31316631-31316641 chr15:31316248-31316256 chr15:31316248-31316256 chr15:31316628-31316639 chr15:31316630-31316642 chr15:31316249-31316256 chr15:31316632-31316640 chr15:31316247-31316257
30	JUND	chr15:31316507-31316988	H1-hESC	embryonic stem cell:	n/a	chr15:31316631-31316641 chr15:31316628-31316639 chr15:31316630-31316642 chr15:31316632-31316640
31	FOSL2	chr15:31316402-31317005	A549	lung:	n/a	chr15:31316631-31316641 chr15:31316628-31316639 chr15:31316630-31316642 chr15:31316632-31316640
32	EP300	chr15:31316385-31317134	SK-N-SH	brain:	n/a	n/a
33	POLR2A	chr15:31316435-31317029	SK-N-SH	brain:	n/a	n/a
34	NFIC	chr15:31316457-31316972	SK-N-SH	brain:	n/a	n/a
35	EP300	chr15:31316473-31317093	A549	lung:	n/a	n/a
36	JUND	chr15:31316449-31317124	SK-N-SH	brain:	n/a	chr15:31316631-31316641 chr15:31316628-31316639 chr15:31316630-31316642 chr15:31316632-31316640
37	TCF12	chr15:31316288-31317836	SK-N-SH	brain:	n/a	chr15:31316555-31316562
38	FOSL2	chr15:31316411-31316978	SK-N-SH	brain:	n/a	chr15:31316631-31316641 chr15:31316628-31316639 chr15:31316630-31316642 chr15:31316632-31316640
39	GATA2	chr15:31316282-31317710	HUVEC	blood vessel:	n/a	chr15:31317461-31317470 chr15:31316560-31316568 chr15:31316630-31316639
40	TEAD4	chr15:31316280-31317121	SK-N-SH	brain:	n/a	n/a
41	TEAD4	chr15:31316479-31317073	ECC-1	luminal epithelium:	n/a	n/a
42	SP1	chr15:31316463-31317120	A549	lung:	n/a	chr15:31316863-31316877
43	TCF12	chr15:31316447-31317135	A549	lung:	n/a	chr15:31316555-31316562
44	PBX3	chr15:31316419-31317003	SK-N-SH	brain:	n/a	n/a
45	GATA3	chr15:31316446-31317635	A549	lung:	n/a	chr15:31317461-31317470 chr15:31316560-31316568 chr15:31316630-31316639
46	MAFK	chr15:31316121-31316972	IMR90	lung:	n/a	n/a
47	TCF12	chr15:31316328-31317749	SK-N-SH	brain:	n/a	chr15:31316555-31316562
48	TEAD4	chr15:31316585-31317013	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr15:31316162..31318225-chr15:31318873..31321784,2	K562	blood:

Variant related genes	Relation type
ENSG00000259720	TF binding region

Extended variants
information (count: 15 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:2)

rs_ID	r²[population]
rs3784590	1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs60293970	1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:13 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv531138	chr15:30653877-31609679	Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	96 gene(s)	inside rSNPs	diseases
2	nsv916936	chr15:30921917-31337510	Active TSS Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
3	nsv525795	chr15:30936285-31324531	Weak transcription Enhancers ZNF genes & repeats Strong transcription Active TSS Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
4	nsv903831	chr15:30986051-31723279	Flanking Active TSS Enhancers Active TSS Weak transcription Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	84 gene(s)	inside rSNPs	diseases
5	nsv1054147	chr15:31014507-31972706	Weak transcription Enhancers Flanking Active TSS Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
6	nsv542306	chr15:31014507-31972706	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	87 gene(s)	inside rSNPs	diseases
7	nsv1036018	chr15:31140415-31544888	Enhancers Flanking Active TSS Active TSS Genic enhancers Strong transcription Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	58 gene(s)	inside rSNPs	diseases
8	esv33507	chr15:31183324-31471023	Weak transcription Enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
9	nsv832952	chr15:31204426-31333998	Strong transcription Enhancers Genic enhancers Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
10	nsv1052722	chr15:31261834-31609680	Flanking Active TSS Weak transcription Enhancers Active TSS Strong transcription Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	52 gene(s)	inside rSNPs	diseases
11	nsv542315	chr15:31261834-31609680	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Genic enhancers ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	52 gene(s)	inside rSNPs	diseases
12	nsv932896	chr15:31292475-31730445	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	59 gene(s)	inside rSNPs	diseases
13	nsv903835	chr15:31312743-31384797	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA	13 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:64 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:31311000-31319600	Strong transcription	Foreskin Melanocyte Primary Cells skin01	Skin
2	chr15:31312400-31317400	Enhancers	Primary B cells from peripheral blood	blood
3	chr15:31313600-31317800	Enhancers	Breast Myoepithelial Primary Cells	Breast
4	chr15:31314800-31317600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
5	chr15:31314800-31318600	Enhancers	Placenta	Placenta
6	chr15:31315000-31317600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
7	chr15:31315000-31318000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr15:31315200-31317200	Enhancers	Placenta Amnion	Placenta Amnion
9	chr15:31315200-31317400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
10	chr15:31315200-31317600	Enhancers	ES-I3 Cell Line	embryonic stem cell
11	chr15:31315200-31317600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
12	chr15:31315200-31317800	Enhancers	Fetal Kidney	kidney
13	chr15:31315200-31317800	Enhancers	NHLF	lung
14	chr15:31315400-31317000	Enhancers	Adipose Nuclei	Adipose
15	chr15:31315400-31317400	Enhancers	Lung	lung
16	chr15:31315400-31317400	Enhancers	NHDF-Ad	bronchial
17	chr15:31315400-31317800	Enhancers	HUES6 Cell Line	embryonic stem cell
18	chr15:31315400-31318400	Enhancers	H1 Cell Line	embryonic stem cell
19	chr15:31315400-31318600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
20	chr15:31315600-31317200	Weak transcription	Primary B cells from cord blood	blood
21	chr15:31315600-31317200	Flanking Active TSS	NHEK	skin
22	chr15:31315600-31317400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr15:31315600-31317400	Enhancers	Sigmoid Colon	Sigmoid Colon
24	chr15:31315600-31317600	Enhancers	H9 Cell Line	embryonic stem cell
25	chr15:31315600-31317600	Enhancers	HSMM	muscle
26	chr15:31315600-31317800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
27	chr15:31315600-31317800	Enhancers	iPS-20b Cell Line	embryonic stem cell
28	chr15:31315600-31317800	Enhancers	NH-A	brain
29	chr15:31315600-31320400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
30	chr15:31315800-31317400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
31	chr15:31315800-31317400	Enhancers	iPS-18 Cell Line	embryonic stem cell
32	chr15:31315800-31317400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr15:31315800-31317600	Enhancers	HUES48 Cell Line	embryonic stem cell
34	chr15:31315800-31317600	Enhancers	iPS-15b Cell Line	embryonic stem cell
35	chr15:31315800-31317800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr15:31315800-31319400	Weak transcription	Primary hematopoietic stem cells	blood
37	chr15:31316000-31317200	Enhancers	HSMMtube	muscle
38	chr15:31316000-31317400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
39	chr15:31316000-31317600	Enhancers	HUES64 Cell Line	embryonic stem cell
40	chr15:31316000-31317600	Enhancers	Skeletal Muscle Male	skeletal muscle
41	chr15:31316200-31317000	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
42	chr15:31316200-31317000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
43	chr15:31316200-31317200	Flanking Active TSS	Muscle Satellite Cultured Cells	--
44	chr15:31316200-31317400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr15:31316200-31317800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
46	chr15:31316200-31317800	Enhancers	Rectal Mucosa Donor 31	rectum
47	chr15:31316200-31318400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
48	chr15:31316400-31317400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
49	chr15:31316400-31324800	Strong transcription	Foreskin Melanocyte Primary Cells skin03	Skin
50	chr15:31316600-31317000	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links